Literature DB >> 11357145

The microenvironment of the tumour-host interface.

L A Liotta1, E C Kohn.   

Abstract

Throughout the entire process of cancer aetiology, progression and metastasis, the microenvironment of the local host tissue can be an active participant. Invasion occurs within a tumour-host microecology, where stroma and tumour cells exchange enzymes and cytokines that modify the local extracellular matrix, stimulate migration, and promote proliferation and survival. A new class of cancer therapies that targets this pathological communication interface between tumour cells and host cells is currently under development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357145     DOI: 10.1038/35077241

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  699 in total

Review 1.  Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors.

Authors:  Edna Cukierman; Daniel E Bassi
Journal:  Semin Cancer Biol       Date:  2010-05-07       Impact factor: 15.707

2.  Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progression.

Authors:  Horace DeLisser; Yong Liu; Pierre-Yves Desprez; Ann Thor; Paraskevei Briasouli; Chakrapong Handumrongkul; Jonathon Wilfong; Garret Yount; Mehdi Nosrati; Sylvia Fong; Emma Shtivelman; Melane Fehrenbach; Gaoyuan Cao; Dan H Moore; Shruti Nayak; Shruti Nyack; Denny Liggitt; Mohammed Kashani-Sabet; Robert Debs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-06       Impact factor: 11.205

3.  Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery.

Authors:  Po-Hao Feng; Chih-Teng Yu; Chin-Yang Wu; Meng-Jung Lee; Wei-Hwa Lee; Liang-Shun Wang; Shu-Min Lin; Jen-Fen Fu; Kang-Yun Lee; Tzung-Hai Yen
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

4.  Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.

Authors:  Liping Huang; Yifei Qin; Qiang Zuo; Kavita Bhatnagar; Jingbo Xiong; Glenn Merlino; Yanlin Yu
Journal:  Int J Cancer       Date:  2017-12-15       Impact factor: 7.396

Review 5.  Immune therapies.

Authors:  Rao H Prabhala; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

6.  Immunotherapy of tumor with vaccine based on basic fibroblast growth factor-activated fibroblasts.

Authors:  Xiuying Li; Yongsheng Wang; Yuwei Zhao; Hengxiu Yang; Aiping Tong; Chengjian Zhao; Huashan Shi; Yang Li; Zhenlin Wang; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

7.  The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.

Authors:  Brigitte Strahm; Adam D Durbin; Elizabeth Sexsmith; David Malkin
Journal:  Clin Exp Metastasis       Date:  2007-09-01       Impact factor: 5.150

8.  Front instabilities and invasiveness of simulated avascular tumors.

Authors:  Nikodem J Popławski; Ubirajara Agero; J Scott Gens; Maciej Swat; James A Glazier; Alexander R A Anderson
Journal:  Bull Math Biol       Date:  2009-02-21       Impact factor: 1.758

9.  Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.

Authors:  Ake Oldberg; Sebastian Kalamajski; Alexei V Salnikov; Linda Stuhr; Matthias Mörgelin; Rolf K Reed; Nils-Erik Heldin; Kristofer Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

10.  Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.

Authors:  Devikala Gurusamy; Jerilyn K Gray; Peterson Pathrose; Rishikesh M Kulkarni; Fred D Finkleman; Susan E Waltz
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.